Celebrating scientific, specialty highlights

Each year, the Plenary session (P151) serves as a high point of the AAD Annual Meeting. The Sunday session will feature a handful of presentations from selected lecturers, as well as a guest speaker. Academy President Henry W. Lim, MD, and President-Elect Suzanne Olbricht, MD, will also address attendees during the session, which occurs from 8 to 11:30 a.m. in Ballroom 20B.

Clarence S. Livingood, MD, Award and Lectureship
Practicing dermatology well is undoubtedly an art. But this art is not simply meaningful for its own sake. Dermatologic care — if accurately measured and studied — can be used to understand the course of disease and improve public health.

Mary-Margaret Chren, MD, will share the progress that has been made in accurate, systematic measurement of skin diseases and dermatologic care in her presentation “The State of (Measuring) the Art of Dermatology.” Dr. Chren is professor of dermatology at Vanderbilt University.

Lila and Murray Gruber Memorial Cancer Research Award and Lectureship
Gene editing with CRISPR technology is transforming biology. Understanding the underlying chemical mechanisms of RNA-guided DNA and RNA cleavage provides a foundation for both conceptual advances and technology development.

In “CRISPR Systems: Nature’s Toolkit for Genome Editing,” Jennifer A. Doudna, PhD, will discuss how the technology inspires the creation of powerful genome engineering tools and enables advances in fundamental biology and applications in medicine. Dr. Doudna is professor and HHMI investigator at University of California, Berkeley.

Eugene J. Van Scott Award for Innovative Therapy of the Skin and Phillip Frost Leadership Lecture
Infliximab/Remicade was developed in a research laboratory and became the first TNF antagonist successfully used in patients. Its success spurred the development and regulatory approval of other TNF antagonists that are used in the treatment of numerous chronic inflammatory autoimmune diseases.

Jan T. Vilcek, MD, PhD, will disclose how his work demonstrates the value of university-based basic research for therapeutic advances and economic progress in “Infliximab: How a TNF Inhibitor Advanced from Modest Beginnings to Unforeseen Therapeutic Success.” Dr. Vilcek is professor emeritus and research professor, department of microbiology, at NYU Langone Health School of Medicine.

Marion B. Sulzberger, MD, Memorial Award and Lectureship
Atopic dermatitis (AD) is the most common inflammatory skin disorder in the developed and urbanized world. It is characterized by intense side effects that affect patients’ quality of life, and is associated with many physical and psychological health conditions.

In his presentation “Atopic Dermatitis,” Alan D. Irvine, MD, DSc, will examine the development of AD over the last decade and its rapid evolvement to new and effective treatments that are on the horizon. Dr. Irvine is professor of dermatology at Trinity College Dublin in Ireland.

Guest Speaker
Physician wellness and burnout is the new epidemic in health care. The ramifications of burnout include a one in four probability of the physician leaving his or her work situation in the ensuing three years, not to mention the risk of intemperate drug use or suicide.

Abraham Verghese, MD, will present “The Pathology Within: Burnout, Wellness, and the Search for Meaning in a Professional Life.” He will share personal narratives and scientific data on physician wellness to suggest a strategy for health care leaders to address this crisis in the profession and for individual physicians to renew their faith. Dr. Verghese is senior associate chair at Stanford University School of Medicine and author of the New York Times bestseller Cutting for Stone.


Return to index